Bioporto AS (OTCPK:THOXF)
$ 0.288 0 (0%) Market Cap: 89.28 Mil Enterprise Value: 79.28 Mil PE Ratio: 0 PB Ratio: 7.41 GF Score: 58/100

Q3 2022 Bioporto A/S Earnings Call Transcript

Nov 09, 2022 / 01:00PM GMT
Release Date Price: $0.64392
Henrik Ekman

Yes, it's 2:00 this afternoon. So welcome to this digital event with BioPorto. My name is Henrik Ekman, and I'm BioTech Equity Analyst here for Andersen Capital. And with me today, I have the pleasure of welcoming the CEO of BioPorto, Tony Pare; and CFO of BioPorto, Neil Goldman.

Before I hand it over to Tony and Neil, just a few remarks. The audience is welcome to post questions in the box, and I will do my best to forward it to the management team. And afterwards, we record this. We will put it on the different media platforms so you can see the event again if you missed something.

So with that, a very warm welcome to 2 of you. I know that your 1-year anniversary Tony, it was yesterday. So a lot of things has happened. And I know you've been very busy in the latest call. So please tell us what the highlights are.

Anthony P. Pare;S;CEO
BioPorto A

/-

Okay. Thank you. Thank you once again for hosting Henrik and a warm welcome to everyone participating on this Q3 2022 financial results and business update

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot